Marco Manganaro

516 total citations
16 papers, 341 citations indexed

About

Marco Manganaro is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Marco Manganaro has authored 16 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Marco Manganaro's work include Renal Diseases and Glomerulopathies (5 papers), Parathyroid Disorders and Treatments (3 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Marco Manganaro is often cited by papers focused on Renal Diseases and Glomerulopathies (5 papers), Parathyroid Disorders and Treatments (3 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Marco Manganaro collaborates with scholars based in Italy, Germany and Russia. Marco Manganaro's co-authors include Patrizia Tosi, Giovanni Palladini, Marisa Santostefano, Anna Maria Di Palma, Martino Marangella, Corrado Vitale, F Linari, Domenico Cosseddu, Dario Roccatello and Gianna Mazzucco and has published in prestigious journals such as American Journal of Kidney Diseases, Gastrointestinal Endoscopy and Nephrology Dialysis Transplantation.

In The Last Decade

Marco Manganaro

15 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Manganaro Italy 8 187 169 102 57 45 16 341
Alexis Harris United States 12 165 0.9× 133 0.8× 96 0.9× 43 0.8× 19 0.4× 21 385
Santiago Mendizábal Spain 12 346 1.9× 110 0.7× 83 0.8× 33 0.6× 71 1.6× 30 589
A. Séchet France 8 175 0.9× 136 0.8× 33 0.3× 27 0.5× 24 0.5× 13 296
H.-V. Gärtner Germany 9 198 1.1× 97 0.6× 83 0.8× 32 0.6× 26 0.6× 17 339
Xu Zeng United States 12 129 0.7× 62 0.4× 59 0.6× 56 1.0× 12 0.3× 28 350
Marisa Giani Italy 14 172 0.9× 118 0.7× 62 0.6× 8 0.1× 56 1.2× 24 413
William E. Smoyer United States 8 421 2.3× 164 1.0× 53 0.5× 40 0.7× 23 0.5× 14 512
Neil D. Ravin United States 4 62 0.3× 100 0.6× 81 0.8× 19 0.3× 61 1.4× 6 388
Michael van Husen Germany 8 245 1.3× 51 0.3× 70 0.7× 15 0.3× 62 1.4× 10 363
Saskia Merkel Germany 6 134 0.7× 61 0.4× 136 1.3× 11 0.2× 52 1.2× 9 356

Countries citing papers authored by Marco Manganaro

Since Specialization
Citations

This map shows the geographic impact of Marco Manganaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Manganaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Manganaro more than expected).

Fields of papers citing papers by Marco Manganaro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Manganaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Manganaro. The network helps show where Marco Manganaro may publish in the future.

Co-authorship network of co-authors of Marco Manganaro

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Manganaro. A scholar is included among the top collaborators of Marco Manganaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Manganaro. Marco Manganaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Barreca, Antonella, Paolo Nozza, Tiziana Vaisitti, et al.. (2022). Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists. Orphanet Journal of Rare Diseases. 17(1). 33–33. 16 indexed citations
2.
Nervo, Alice, Francesca Retta, Alberto Ragni, et al.. (2021). Nephrotoxicity in advanced thyroid cancer treated with tyrosine kinase inhibitors: An update. Critical Reviews in Oncology/Hematology. 168. 103533–103533. 10 indexed citations
3.
Numico, Gianmauro, Roberto Ippoliti, Guido Chichino, et al.. (2020). Organizational determinants of hospital stay: establishing the basis of a widespread action on more efficient pathways in medical units. Internal and Emergency Medicine. 15(6). 1011–1019. 4 indexed citations
4.
Rollino, Cristiana, F Giacchino, Silvana Savoldi, et al.. (2012). [Restrospective analysis of the renal biopsy activity in Piedmont].. PubMed. 29(4). 473–83. 1 indexed citations
5.
Monteverde, A, et al.. (2009). Cytoreductive surgery and ovarian carcinoma.. PubMed. 80(3). 230–3. 2 indexed citations
6.
Manganaro, Marco, et al.. (2009). Ovarian cancer: lymph node metastases.. PubMed. 30(3). 289–91. 17 indexed citations
7.
Manganaro, Marco, Giovanni Palladini, Marisa Santostefano, et al.. (2007). Renal involvement in systemic amyloidosis: An Italian collaborative study on survival and renal outcome. Nephrology Dialysis Transplantation. 23(3). 941–951. 84 indexed citations
8.
Santostefano, Marisa, Marco Manganaro, Giovanni Palladini, et al.. (2007). Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis. Nephrology Dialysis Transplantation. 22(6). 1608–1618. 58 indexed citations
9.
Scarpulla, G., et al.. (2006). Evaluation of 96-hour pH monitoring with the Bravo wireless system in 60 patients. Digestive and Liver Disease. 38. S11–S11. 1 indexed citations
10.
Scarpulla, G., et al.. (2006). Evaluation of 96-Hour pH Monitoring with the Bravo Wireless System in 60 Patients. Gastrointestinal Endoscopy. 63(5). AB126–AB126. 1 indexed citations
11.
Vitale, Corrado, et al.. (1999). [Clinical and metabolic features of renal calculi in adults in regard to age of onset].. PubMed. 51(2). 71–4. 4 indexed citations
12.
Fracchia, M., et al.. (1997). Minimal change nephropathy presenting in a patient with primary sclerosing cholangitis.. PubMed. 29(3). 267–9. 1 indexed citations
13.
Stratta, Piero, Giuseppe Segoloni, Caterina Canavese, et al.. (1996). Incidence of biopsy-proven primary glomerulonephritis in an Italian Province. American Journal of Kidney Diseases. 27(5). 631–639. 69 indexed citations
14.
Manganaro, Marco, Michael S. Bruno, Nicoletta Ravarino, et al.. (1994). [Renal damage in rheumatoid arthritis].. PubMed. 46(1). 55–60. 2 indexed citations
15.
Marangella, Martino, Corrado Vitale, Marco Manganaro, et al.. (1991). Renal Handling of Citrate in Chronic Renal Insufficiency. ˜The œNephron journals/Nephron journals. 57(4). 439–443. 25 indexed citations
16.
Marangella, Martino, Michele Bruno, Domenico Cosseddu, et al.. (1990). Prevalence of Chronic Renal Insufficiency in the Course of Idiopathic Recurrent Calcium Stone Disease: Risk Factors and Patterns of Progression. ˜The œNephron journals/Nephron journals. 54(4). 302–306. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026